Gala Review

Gala in one line: a flat-rate, all-doses-included GLP-1 subscription that asks for a year up front

Gala — run by the Delaware company AI Coaching Inc., doing business as Gala GLP-1 — sells compounded semaglutide and compounded tirzepatide on a yearly plan. The promise is simple: pay one flat monthly rate and every dose you ever titrate up to is included, with free shipping on top. If you already know you want a compounded GLP-1, hate surprise upcharges as your dose climbs, and are comfortable committing to a 12-month subscription, Gala is built squarely for you. If you want to go month-to-month or know exactly which pharmacy is making your medication, this is not the right fit.

How the pricing actually works — flat, but annual

Gala's headline structure is a flat yearly subscription where the price doesn't change as your dose increases. The company states plainly that 'if a higher dose is recommended, it will be available at no additional cost,' which removes the single biggest budgeting headache with GLP-1 therapy — most providers charge more as you move up the titration ladder. For people who want a cheaper on-ramp, there's a separate microdosing tirzepatide tier at $149/mo, a deliberately sub-therapeutic starting protocol. That sits comfortably under the category median of $170/mo.

The honest catch: the flat rate is tied to a yearly commitment, and Gala does not publish a standalone month-to-month price. So the attractive number assumes you'll stay enrolled for 12 months. Read the cancellation terms before you sign — the site says you can cancel anytime and that provider support is included for as long as you're on the program, but the discount math is built around the annual plan.

• Compounded GLP-1 (semaglutide) and GLP-1/GIP (tirzepatide): flat yearly subscription, all titration doses included
• Microdosing tirzepatide: $149/mo, a lower-cost sub-therapeutic starting tier
• Brand-name Ozempic: offered, but priced well above what peers charge for brand GLP-1s
• Free shipping and provider visits are bundled in — no separate consult or delivery fees

The medications: two compounded molecules, plus brand Ozempic

Most compounded telehealth brands give you one molecule. Gala explicitly offers both compounded semaglutide and compounded tirzepatide, so you and your prescriber can pick the single-agonist or the dual GLP-1/GIP route without switching providers. Brand-name Ozempic is also on the menu for people who specifically want the FDA-approved pen — though Gala's brand price is noticeably higher than competitors who sell the same drug, so it's the weakest value in the lineup. An oral Wegovy pill is listed as 'coming soon' with pricing 'at launch,' meaning it is not something you can actually buy today.

What genuinely sets Gala apart

Two things. First, the no-upcharge-on-dose flat model is a real differentiator — it's spelled out on the site, and it matters most for tirzepatide patients who expect to climb to higher doses. Second, the breadth: compounded sema, compounded tirz, brand Ozempic, and a budget microdosing tier under one roof, with a claim of licensed providers in all 50 states and free nationwide shipping. Prescribing runs through licensed clinicians affiliated with OpenLoop medical groups, with Gala handling the technology and administrative side.

The trust gaps you should weigh

Gala displays a LegitScript seal and discloses HIPAA compliance, and there are no FDA warning letters on file for Gala GLP-1 or AI Coaching Inc. Those are points in its favor. But there are real, honest gaps. Gala does not name its compounding pharmacies — it refers only to 'a wide network of pharmacies across all 50 states.' For a YMYL medical product, not knowing which facility mixes your injectable is a meaningful blind spot. The all-50-states claim is also gated behind the signup intake rather than published as a per-state list, which costs it points. You can read how we weigh these signals in our scoring methodology.

Who should choose Gala

• People who want flat, predictable pricing that won't rise as their dose increases
• Patients who want both compounded semaglutide and tirzepatide available from one provider
• Budget-focused starters drawn to the $149/mo microdosing tier
• Anyone who values bundled free shipping and an included provider visit

Who should skip it

• Anyone who wants a true month-to-month option without a yearly commitment
• Buyers who insist on knowing exactly which accredited pharmacy fills their prescription
• People shopping for brand Ozempic on price — Gala's brand rate is higher than peers
• Anyone waiting on an oral GLP-1 today (the Wegovy pill is still 'coming soon')

Bottom line

Gala is a legitimate-looking, LegitScript-certified platform with a genuinely useful pricing idea: a flat yearly rate that covers every dose, plus a cheap microdosing entry point at $149/mo against a $170/mo category median. For a committed patient who wants compounded semaglutide or tirzepatide without dose-based upcharges, it's worth a serious look. Just go in clear-eyed about the two trade-offs — the discount is built around a 12-month subscription, and Gala won't tell you which pharmacy makes your medication. If those don't bother you, it's a strong-value pick; if they do, compare it against providers that name their pharmacy and offer monthly billing.

For a side-by-side, Yucca Health ($146/month) and altRX ($149/month) are the most comparable options to weigh against Gala.